Drugs & TargetsFree Polaris Group’s lead product candidate, ADI-PEG 20 receives US and EU orphan designations January 09, 2015Vol.41 No.01
Drugs & TargetsFree Amgen and Kite Pharma entered into a strategic research collaboration January 09, 2015Vol.41 No.01
FreeIn Brief NCI Director Harold Varmus addresses NCI staff and grantees with an outlook on the new year January 09, 2015Vol.41 No.01
Drugs & TargetsFree FDA approved a supplemental biologics license application for Gazyva January 06, 2015Vol.41 No.01
FreeTCCL Archive Cyramza Combination Approved in Advanced Gastric Cancer December 01, 2014Vol.37 No.11
